share_log

Avadel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(13.8%),Janus Henderson Biotech Innovation Master Fund Ltd(5.0%)

SEC ·  Nov 15 00:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more